Bright Minds Biosciences Inc. (NASDAQ: DRUG) is a biotechnology company focused on developing novel therapies for neurological and neuropsychiatric disorders. One such therapy involves healing the...
Bright Minds Biosciences has announced the commencement of its Phase 2 clinical trial for BMB-101.
On September 25th, the company will host an event to...
RenovoRx's TAMP™ technology delivers chemotherapy directly to tumors, reducing side effects and improving treatment efficacy.
With a projected 330% price increase, RenovoRx is gaining investor...
Bright Minds Biosciences Inc. (NASDAQ: DRUG) is a biotechnology company focused on developing novel therapies for neurological and neuropsychiatric disorders, such as healing the central nervous...
2024 sees a biotech rebound, with over 15 IPOs by mid-year and capital inflows increasing across the sector.
Gene therapy and oncology are driving biotech...